S. G. Eckhardt

Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity.

A. Tolcher, T. Whiteside, J. Stephenson, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.

G. Weiss, D. V. Von Hoff, S. Baker, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Suzanne F. Jones, D. V. Von Hoff, H. Burris, 1999, Cancer Chemotherapy and Pharmacology.

Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.

M. Hidalgo, A. Tolcher, G. Weiss, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.